REDWOOD CITY, Calif.--(BUSINESS WIRE)--Oct. 24, 2012--
Codexis, Inc. (NASDAQ: CDXS), a developer of cost-advantaged processes
for the production of biofuels, bio-based chemicals, and
pharmaceuticals, today announced it will host a conference call and
webcast on Wednesday, November 7, 2012 at 4:30 p.m. Eastern Time to
discuss its third quarter 2012 financial results for the period ended
September 30, 2012. The call and webcast will follow the release of
third quarter financial results after market close. A recorded version
of the call will be available approximately one hour after the call on
the Investors section of the company's website, www.codexis.com,
and will be archived for up to 30 days.
|
|
|
|
|
|
|
What:
|
|
|
|
Codexis' third quarter 2012 financial results conference call and
webcast
|
|
|
|
|
|
|
|
Date:
|
|
|
|
Wednesday, November 7, 2012
|
|
|
|
|
|
|
|
Time:
|
|
|
|
4:30 p.m. ET
|
|
|
|
|
|
|
|
Live Call:
|
|
|
|
US: 866-788-0541
|
|
|
|
|
|
International: 857-350-1679
|
|
|
|
|
|
Passcode: 54501345
|
|
|
|
|
|
|
|
Replay:
|
|
|
|
US: 888-286-8010
|
|
|
|
|
|
International: 617-801-6888
|
|
|
|
|
|
Passcode: 65902545
|
|
|
|
|
|
|
About Codexis, Inc.
Codexis, Inc. is a developer of cost-advantaged processes for the
production of biofuels, bio-based chemicals and pharmaceuticals.
Codexis' product lines include CodeXyme™ cellulase enzymes and CodeXol™
detergent alcohol. Partners and customers include global leaders such as
Merck, Pfizer and Teva. For more information, see www.codexis.com.
Source: Codexis, Inc.
Codexis, Inc.
Investors:
Paul Cox, 212-362-1200
ir@codexis.com
Media:
Kelly
McAlearney, 415-503-4073
media@codexis.com
